Related Experiment Videos
Eculizumab in Systemic Lupus Erythematosus Complicated with Thrombotic Microangiopathy
Azar Nickavar1, Nafiseh Mortazavi2, Shima Salehi3
1Professor of Pediatric Nephrology, Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abstract:
Thrombotic microangiopathy (TMA) is a rare but serious complication of systemic lupus erythematosus (SLE) in children, which is often resistant to different medical treatments. This is the report of a 13 years old female with a newly diagnosed SLE, complicated with a refractory course of SLE-TMA. Eculizumab had an effective therapeutic impact with clinical and laboratory improvement of TMA.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies